Publication | Open Access

B1-01: A multi-centre phase IIB randomized controlled study of BLP25 liposome vaccine (L-BLP25 or Stimuvax) for active specific immunotherapy of non-small cell lung cancer (NSCLC): updated survival analysis

MedicineImmunologyVaccine TrialTherapeutic VaccineMulti-centre Phase IibActive Specific ImmunotherapyImmunotherapyOncologyRadiation OncologyLung Cancer